High-sensitivity Cardiac Troponin: What Does It Mean for Your Laboratory, Your Clinicians and Your Patients? H&H Testing: The Rule of Three Is Still Relevant New Challenges for Microbiology Laboratories in Antibiotic Susceptibility Testing Procalcitonin and its Role as a Biomarker for the Management of Sepsis Speakers: Allison Chambliss, Ph.D., Keck School of Medicine of University of Southern California Paramjit Sandhu, M.D., MPH, Centers for Disease Control and Prevention Īlan Wu, Ph.D., University of California San Francisco General Hospitalīeckman Coulter In-booth Education Sessions Moderator: Robert Christenson, Ph.D., University of Maryland School of Medicine The ASSESS Trial: A Multi-instrument Evaluation of 13 Commercial Troponin Assays, Sample Analysis in a Common Cohort of Samples Wednesday, August 2, 10:30 am to 12:00 pm
Speaker: Mike Samoszuk, M.D., Beckman Coulter In this session, the clinical and laboratory-related characteristics of sepsis are described, with special emphasis on hematologic manifestations of sepsis. Laboratorians and healthcare professionals can learn more about Beckman Coulter Diagnostics solutions by participating in the company-hosted educational programs and in-booth presentations listed below. With a rich history and tradition of innovation, the diagnostic companies of Danaher remain committed to helping healthcare systems build comprehensive and efficient diagnostic services to meet the evolving demands of highly integrated and coordinated healthcare delivery models. The breadth of offerings extends from established to highly advanced diagnostic technologies for clinical and anatomic pathology laboratories and point-of-care testing. The launch of these new products further expands portfolio spanning multiple disciplines, further expands the clinical diagnostic solutions available to customers through Danaher Corporation's network of companies, which include Beckman Coulter, Cepheid, Leica Biosystems, Radiometer and SCIEX Diagnostics.
BECKMAN COULTER MICROSCAN UPDATE
DxM 1096 MicroScan WalkAway System,*** featuring a design update for ease-of-use.DxH 500 hematology analyzer, ** designed for physician offices and other laboratories with low-volume workloads.Access 2 immunoassay analyzer, featuring new enhancements for ease-of-use and productivity.Access AMH assay* for women's health and fertility assessments.Procalcitonin chemistry assay for early detection and management of bacterial infections.DxC 700 AU chemistry analyzer, ideal for mid- to high-volume clinical laboratories.
Helping serve patients in the safest and most efficient manner is our job, and, in fact, it is our vision to advance healthcare for every person."Īt the heart of the Beckman Coulter Diagnostics Difference, are the company's comprehensive high-quality clinical diagnostics solutions-exemplified by several new products featured in the booth this year, including the: "We believe that patient care begins with the clinical laboratory. We know that, as significant changes occur in the healthcare landscape, our clinical partners face a host of challenges that require new ways of thinking," said Arnd Kaldowski, president, Beckman Coulter Diagnostics and Group Executive Diagnostics for Danaher. "We look forward to collaborating with our colleagues and partners at AACC this year to further relationships and deepen understanding.
0 kommentar(er)
